Atlas Trials

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00153075 · COMPLETED

Trial details

NCT number
NCT00153075
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic ObstructiveAsthma
Start date
2005-09-26
Primary completion
2005-12-07
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.